news
The SARS-CoV-2 Spike protein from a COVID-19 vaccine candidate has…
11 August 2020 | By Victoria Rees (Drug Target Review)
The SARS-CoV-2 Spike protein from a COVID-19 vaccine candidate has been characterised by researchers, supporting the neutralising antibody response it elicits.